Outcomes of the cyclophosphamide, vincristine, prednisone (CVP) +/- rituximab (R-CVP) regimen in older patients with newly diagnosed Ph- acute lymphoblastic leukemia
| Autor: | Alison Walker, Bhavana Bhatnagar, Gregory K. Behbehani, Nicole Grieselhuber, Caner Saygin, Karilyn Larkin, John C. Byrd, Sumithira Vasu, Meixiao Long, James S. Blachly, Alice S. Mims |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Cancer Research
medicine.medical_specialty Newly diagnosed Gastroenterology Older patients Prednisone Internal medicine Antineoplastic Combined Chemotherapy Protocols medicine Humans Cyclophosphamide R-CVP Regimen Aged Aged 80 and over business.industry Age Factors Hematology Precursor Cell Lymphoblastic Leukemia-Lymphoma Prognosis Ph+ acute lymphoblastic leukemia Treatment Outcome Oncology Cyclophosphamide/vincristine Vincristine Rituximab business medicine.drug |
| Zdroj: | Leukemia research. 89 |
| ISSN: | 1873-5835 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect